Todd W. Miller

5.5k total citations
79 papers, 4.1k citations indexed

About

Todd W. Miller is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Todd W. Miller has authored 79 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 41 papers in Oncology and 20 papers in Genetics. Recurrent topics in Todd W. Miller's work include PI3K/AKT/mTOR signaling in cancer (24 papers), HER2/EGFR in Cancer Research (14 papers) and Estrogen and related hormone effects (14 papers). Todd W. Miller is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (24 papers), HER2/EGFR in Cancer Research (14 papers) and Estrogen and related hormone effects (14 papers). Todd W. Miller collaborates with scholars based in United States, Switzerland and United Kingdom. Todd W. Miller's co-authors include Carlos L. Arteaga, Justin M. Balko, Gordon B. Mills, Ana M. González-Angulo, Lloye M. Dillon, Emily M. Fox, Brent N. Rexer, Joan T. Garrett, Eugene Demidenko and Yu Shyr and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Todd W. Miller

78 papers receiving 4.1k citations

Peers

Todd W. Miller

ONCOL

PRM

GENET

Stefano Pepe Italy

Pedram Argani United States

Ana Vivancos Spain

Elgene Lim Australia

Johan Vallon‐Christersson Sweden

Sandra E. Dunn Canada

Dvorit Samid United States

Sophie Vacher France

Monica R. Maiello Italy

Andrew H. Sims United Kingdom

Stefano Pepe Italy

Todd W. Miller

2.6k ×1.0

2.5k ×1.4

ONCOL

1.1k ×0.9

PRM

647 ×0.7

366 ×0.6

GENET

Citations per year, relative to Todd W. Miller Todd W. Miller (= 1×) peers Stefano Pepe

Countries citing papers authored by Todd W. Miller

Since Specialization

Citations

This map shows the geographic impact of Todd W. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd W. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd W. Miller more than expected).

Fields of papers citing papers by Todd W. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd W. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd W. Miller. The network helps show where Todd W. Miller may publish in the future.

Co-authorship network of co-authors of Todd W. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Todd W. Miller. A scholar is included among the top collaborators of Todd W. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd W. Miller. Todd W. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marotti, Jonathan D., Youdinghuan Chen, Roberto Salgado, et al.. (2025). Quantitative proteomics analysis of triple-negative breast cancers. npj Precision Oncology. 9(1). 117–117. 1 indexed citations

Traphagen, Nicole A., Gary N. Schwartz, Jonathan D. Marotti, et al.. (2023). Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer. Clinical Cancer Research. 29(18). 3717–3728. 8 indexed citations

Schwartz, Gary N., Peter A. Kaufman, Karthik V. Giridhar, et al.. (2023). Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. Clinical Cancer Research. 29(15). 2767–2773. 3 indexed citations

Traphagen, Nicole A., Jennifer Fields, Kevin Shee, et al.. (2020). AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells. Clinical Cancer Research. 26(14). 3707–3719. 64 indexed citations

Shee, Kevin, Matthew Ung, Nicole A. Traphagen, et al.. (2019). A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition. Clinical Cancer Research. 26(1). 159–170. 1 indexed citations

Demidenko, Eugene & Todd W. Miller. (2019). Statistical determination of synergy based on Bliss definition of drugs independence. PLoS ONE. 14(11). e0224137–e0224137. 95 indexed citations

Shee, Kevin, Kristen E. Muller, Jonathan D. Marotti, et al.. (2018). Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era. American Journal Of Pathology. 189(5). 956–965. 12 indexed citations

Dillon, Lloye M., Stephanie J. Bouley, Rachele Rosati, et al.. (2016). Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER+ Breast Cancer. Clinical Cancer Research. 23(11). 2795–2805. 24 indexed citations

Yang, Wei, Lloye M. Dillon, Kevin Shee, et al.. (2016). Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA -Mutant Breast Cancer. Clinical Cancer Research. 22(9). 2250–2260. 27 indexed citations

10.

Muller, Kristen E., Jonathan D. Marotti, Francine B. de Abreu, et al.. (2016). Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers. Experimental and Molecular Pathology. 100(3). 421–425. 27 indexed citations

11.

Balko, Justin M., Luis J. Schwarz, Neil E. Bhola, et al.. (2013). Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer. Cancer Research. 73(20). 6346–6358. 122 indexed citations

12.

Sangai, Takafumi, Argun Akçakanat, Huiqin Chen, et al.. (2012). Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer. Clinical Cancer Research. 18(20). 5816–5828. 124 indexed citations

13.

Miller, Todd W., Justin M. Balko, Zara Ghazoui, et al.. (2011). A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance. Clinical Cancer Research. 17(7). 2024–2034. 85 indexed citations

14.

Fox, Emily M., Todd W. Miller, Justin M. Balko, et al.. (2011). A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer. Cancer Research. 71(21). 6773–6784. 131 indexed citations

15.

Yang, Xuemei, Alexa B. Turke, Jie Qi, et al.. (2011). Using Tandem Mass Spectrometry in Targeted Mode to Identify Activators of Class IA PI3K in Cancer. Cancer Research. 71(18). 5965–5975. 9 indexed citations

16.

Miller, Todd W., Justin M. Balko, Emily M. Fox, et al.. (2011). ERα-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer. Cancer Discovery. 1(4). 338–351. 241 indexed citations

17.

Miller, Todd W., Brent N. Rexer, Joan T. Garrett, & Carlos L. Arteaga. (2011). Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. Breast Cancer Research. 13(6). 224–224. 359 indexed citations

18.

Miller, Todd W., James T. Forbes, Chirayu Shah, et al.. (2009). Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells. Clinical Cancer Research. 15(23). 7266–7276. 99 indexed citations

19.

Miller, Todd W., Marianela Pérez-Torres, Archana Narasanna, et al.. (2009). Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer. Cancer Research. 69(10). 4192–4201. 141 indexed citations

20.

Shin, Incheol, Todd W. Miller, & Carlos L. Arteaga. (2006). ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors. Clinical Cancer Research. 12(3). 1008s–1012s. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact